<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Lucke, Matthias</dc:creator>
  <dc:creator>Mottas, Inès</dc:creator>
  <dc:creator>Herbst, Tina</dc:creator>
  <dc:creator>Hotz, Christian</dc:creator>
  <dc:creator>Römer, Lin</dc:creator>
  <dc:creator>Schierling, Martina</dc:creator>
  <dc:creator>M.Herold, Heike</dc:creator>
  <dc:creator>Slotta, Ute</dc:creator>
  <dc:creator>Spinetti, Thibaud</dc:creator>
  <dc:creator>Scheibel, Thomas</dc:creator>
  <dc:creator>Winter, Gerhard</dc:creator>
  <dc:creator>Bourquin, Carole</dc:creator>
  <dc:creator>Engert, Julia</dc:creator>
  <dc:date>2018-07-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The generation of strong T-cell immunity is one of the main challenges for the  development of successful vaccines against cancer and major infectious diseases.  Here we have engineered spider silk particles as delivery system for a peptide-based  vaccination that leads to effective priming of cytotoxic T-cells. The recombinant spider  silk protein eADF4(C16) was fused to the antigenic peptide from ovalbumin, either  without linker or with a cathepsin cleavable peptide linker. Particles prepared from the  hybrid proteins were taken up by dendritic cells, which are essential for T-cell priming,  and successfully activated cytotoxic T-cells, without signs of immunotoxicity or  unspecific immunostimulatory activity. Upon subcutaneous injection in mice, the  particles were taken up by dendritic cells and accumulated in the lymph nodes, where  immune responses are generated. Particles from hybrid proteins containing a  cathepsin-cleavable linker induced a strong antigen-specific proliferation of cytotoxic  T-cells in vivo, even in the absence of a vaccine adjuvant. We thus demonstrate the  efficacy of a new vaccine strategy using a protein-based all-in-one vaccination  system, where spider silk particles serve as carriers with an incorporated peptide  antigen. Our study further suggests that engineered spider silk-based vaccines are  extremely stable, easy to manufacture, and readily customizable.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307094</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307094/files/mot_ehs.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.biomaterials.2018.04.008</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Biomaterials. - 2018, vol. 172, p. 105–115</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Engineered hybrid spider silk particles as delivery system for peptide vaccines</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
